Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
基本信息
- 批准号:7619271
- 负责人:
- 金额:$ 29.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-02 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAIDS neuropathyAIDS/HIV problemActinsAddressAdhesivesAffectAnimal ModelAnimalsAntibodiesAwardBiochemicalBiologyBlood - brain barrier anatomyBrainBrain InjuriesCCL2 geneCXCL10 geneCell CommunicationCell NucleusCell physiologyCellsCellular MorphologyCellular StructuresCentral Nervous System DiseasesCoculture TechniquesCognitive deficitsComplexCytokine Inducible SH2-Containing ProteinCytoskeletonDNA BindingDNA Sequence RearrangementDementiaElectrical ResistanceEncephalitisEndothelial CellsEndotheliumEventExtravasationFamily memberFigs - dietaryFocal AdhesionsFunctional disorderGenetic TranscriptionGenomicsGliosisHIVHIV Envelope Protein gp120HIV InfectionsHIV encephalitisHIV-1HumanIL8 geneImmuneImmunohistochemistryImpaired cognitionImpairmentIn VitroIndividualInfectionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6Janus kinaseLaboratoriesLeadLeukocytesLifeLigandsLinkMediatingMembraneMessenger RNAMicrofilamentsMicrogliaModelingMolecularMusNOD/SCID mouseNervous System TraumaNervous system structureNeurogliaNeurologicNeuronal InjuryNeuronsNeuropathogenesisNeurotoxinsPathogenesisPathway interactionsPatientsPermeabilityPlayProteinsProteomicsResearchResearch SupportRoleSTAT1 geneSerineSignal TransductionStress FibersStructureSystemTestingTherapeuticTight JunctionsTimeTyrosineViralViral ProteinsViremiaVirusWorkadherent junctionautocrinebasebiological systemschemokinecytokineexposed human populationfludarabinein vivoinhibitor/antagonistinjuredinsightmacrophagemigrationmonocytenovelparacrinepreventprotein inhibitor of activated STAT 1receptor bindingresearch studyresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Blood-brain barrier (BBB) compromise is common in HIV-1-infected individuals and is implicated in the pathogenesis of HIV-1-associated dementia. Breech of this barrier allows progeny virus and activated, HIV-1- infected macrophages to infiltrate the brain, disseminate virus to perivascular macrophages and microglia. Infected cells in the brain secrete neurotoxins that affect neuronal function and lead to cognitive impairments. Therefore, a principal means to prevent neurological injury following HIV-1 infection is to halt BBB injury. To accomplish this, the mechanisms through which HIV infection leads to BBB dysfunction need be elucidated. Using a defined platform, integrating genomics, proteomics and cell biological systems, we recently demonstrated that HIV-1-infected macrophages engage human brain microvascular endothelial cells and incite an autocrine and paracrine cascade of pro-inflammatory cytokines and chemokines that ultimately affect the structure and integrity of the BBB. Our preliminary work, in vitro and using brain microvessels from HIV- infected humans, demonstrated that HIV-1-induced inflammation and injury to human brain endothelial cells involve activation of STAT1 at serine 727. We further demonstrated that Fludarabine, a specific STAT1 inhibitor, reduced inflammation and viral infectivity, reduced viremia, gliosis and macrophage infiltration in the brain of HIV encephalitic mice. Based on these observations, it is our hypothesis that STAT1 play a critical role in HIV-1-induced BBB dysfunction and modulates macrophage-endothelial interactions. We hypothesize that by affecting STAT1 pathways, BBB dysfunction can be reversed leading to protection of the barrier's integrity. This hypothesis will be addressed in the following specific aims: in Aim 1, we will investigate the effects of HIV-1 and viral-induced cytokines on the endothelial cytoskeleton, and decipher the role of STAT-1 on these alterations. This is based on our preliminary observation that HIV-1-infected macrophage inflammatory responses alter the endothelial cytoskeleton. In Aim 2, we will investigate the role of STAT1 in endothelial cell function and endothelial-macrophage interaction in the context of HIV infection. Finally in Aim 3, we will test our hypothesis that STAT1 mediates HIV-induced BBB injury in vivo, using an animal model of HIV-1 encephalitis. These studies will provide insight into the mechanisms by which cytokines and HIV transduce signals at the BBB, dysregulations that occurs in HIV infection and lead to BBB dysfunction. Relevance: Forty-million people in the world are currently living with HIV/AIDS; and neurological complications are common among these infected individuals. HIV infiltrates the brain damaging the brain endothelium, then infects brain macrophages and injures neurons, resulting in cognitive deficits and sometimes dementia. The work in this proposal will help us understand how HIV damages the brain endothelium and enters the brain, how to prevent viral entry into the brain, and HIV-associated dementia.
描述(由申请人提供):血脑屏障(BBB)妥协在HIV-1感染的个体中很常见,与HIV-1相关痴呆的发病机理有关。这种屏障的臀位允许后代病毒并激活,HIV-1感染的巨噬细胞浸润大脑,将病毒传播到血管周围巨噬细胞和小胶质细胞。脑中感染的细胞会分泌影响神经元功能并导致认知障碍的神经毒素。因此,预防HIV-1感染后神经损伤的主要手段是阻止BBB损伤。为此,需要阐明HIV感染导致BBB功能障碍的机制。使用定义的平台,整合基因组学,蛋白质组学和细胞生物系统,我们最近证明,HIV-1感染的巨噬细胞吸引了人脑微血管内皮细胞,并促进了促炎细胞因子和趋化因子和趋化因子的自分泌和旁分泌级联反应,从而最终影响BBB的结构和完整性。 Our preliminary work, in vitro and using brain microvessels from HIV- infected humans, demonstrated that HIV-1-induced inflammation and injury to human brain endothelial cells involve activation of STAT1 at serine 727. We further demonstrated that Fludarabine, a specific STAT1 inhibitor, reduced inflammation and viral infectivity, reduced viremia, gliosis and macrophage infiltration in the brain of HIV脑小鼠。基于这些观察结果,我们的假设是STAT1在HIV-1诱导的BBB功能障碍中起关键作用,并调节巨噬细胞 - 内皮相互作用。我们假设通过影响STAT1途径,BBB功能障碍可以逆转,从而保护屏障的完整性。该假设将在以下特定目的中解决:在AIM 1中,我们将研究HIV-1和病毒诱导的细胞因子对内皮细胞骨架的影响,并破译STAT-1对这些改变的作用。这是基于我们的初步观察结果,即HIV-1感染的巨噬细胞炎症反应改变了内皮细胞骨架。在AIM 2中,我们将研究STAT1在HIV感染的情况下STAT1在内皮细胞功能和内皮巨噬细胞相互作用中的作用。最终,在AIM 3中,我们将使用HIV-1脑炎动物模型来测试STAT1介导HIV诱导的BBB损伤的假设。这些研究将提供有关细胞因子和HIV转导信号在BBB,失调并导致HIV感染并导致BBB功能障碍的机制。相关性:目前,世界上有4000万人患有艾滋病毒/艾滋病;在这些受感染的个体中,神经系统并发症很常见。艾滋病毒浸润大脑会损害脑内皮,然后感染脑巨噬细胞并损害神经元,导致认知缺陷,有时甚至是痴呆症。该提案中的工作将有助于我们了解艾滋病毒如何损害脑内皮并进入大脑,如何防止病毒进入大脑以及与HIV相关的痴呆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGETTE D. KANMOGNE其他文献
GEORGETTE D. KANMOGNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGETTE D. KANMOGNE', 18)}}的其他基金
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
- 批准号:
10700624 - 财政年份:2023
- 资助金额:
$ 29.4万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默氏病,例如 HIV 感染中的脑病理学
- 批准号:
10161318 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默病,例如 HIV 感染中的脑病理学
- 批准号:
10301369 - 财政年份:2020
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8599489 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8426089 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8779742 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8257050 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
8055998 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
7806523 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
8247819 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别:
相似海外基金
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8919084 - 财政年份:2014
- 资助金额:
$ 29.4万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8584593 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8701265 - 财政年份:2013
- 资助金额:
$ 29.4万 - 项目类别:
Opioid Drug abuse in the context of opportunistic infection increases susceptibil
阿片类药物滥用会增加机会性感染的易感性
- 批准号:
8404078 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别:
Opioid Drug abuse in the context of opportunistic infection increases susceptibil
阿片类药物滥用会增加机会性感染的易感性
- 批准号:
8485569 - 财政年份:2012
- 资助金额:
$ 29.4万 - 项目类别: